{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:27:00Z","timestamp":1772101620181,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["No. ZR2023QH483"],"award-info":[{"award-number":["No. ZR2023QH483"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Doctoral Research Fund of Jining No.1 People\u2019s Hospital","award":["2022-BS-009"],"award-info":[{"award-number":["2022-BS-009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38613-5","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:46:45Z","timestamp":1770421605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNMT3A p.R882C driven proliferation and anti-apoptotic effects in pancreatic cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhen","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"38613_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"38613_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"38613_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12885-022-09279-9","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC Cancer. 22, 186 (2022).","journal-title":"BMC Cancer"},{"key":"38613_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-23-0519","volume":"23","author":"MT Than","year":"2024","unstructured":"Than, M. T., O\u2019Hara, M., Stanger, B. Z. & Reiss, K. A. KRAS-Driven tumorigenesis and KRAS-Driven therapy in pancreatic adenocarcinoma. Mol. Cancer Ther. 23, 1378\u20131388 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"38613_CR5","doi-asserted-by":"crossref","unstructured":"Kimura, H. et al. P. Familial Pancreatic Cancer Genome Sequencing, N.J. Roberts, Functional CDKN2A Assay Identifies Frequent Deleterious Alleles Misclassified as Variants of Uncertain Significance Vol. 11 (Elife, 2022).","DOI":"10.7554\/eLife.71137"},{"key":"38613_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41420-024-02020-4","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1\/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma. Cell. Death Discov. 10, 252 (2024).","journal-title":"Cell. Death Discov"},{"key":"38613_CR7","first-page":"875","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe, J. S. et al. Enhancer Reprogramming Promotes Pancreat. Cancer Metastasis Cell., 170 875\u2013888e820. (2017).","journal-title":"Enhancer Reprogramming Promotes Pancreat. Cancer Metastasis Cell."},{"key":"38613_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12029-024-01149-w","volume":"56","author":"T Hoang","year":"2025","unstructured":"Hoang, T. & Tsang, E. S. Advances in novel targeted therapies for pancreatic adenocarcinoma. J. Gastrointest. Cancer. 56, 38 (2025).","journal-title":"J. Gastrointest. Cancer"},{"key":"38613_CR9","doi-asserted-by":"publisher","first-page":"22148","DOI":"10.1039\/D1RA90125G","volume":"11","author":"A Akhundi","year":"2021","unstructured":"Akhundi, A. & Habibi-Yangjeh, A. Correction: Facile Preparation of novel quaternary g-C(3)N(4)\/Fe(3)O(4)\/AgI\/Bi(2)S(3) nanocomposites: magnetically separable visible-light-driven photocatalysts with significantly enhanced activity. RSC Adv. 11, 22148 (2021).","journal-title":"RSC Adv."},{"key":"38613_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature25477","volume":"554","author":"ZM Zhang","year":"2018","unstructured":"Zhang, Z. M. et al. Structural basis for DNMT3A-mediated de Novo DNA methylation. Nature 554, 387\u2013391 (2018).","journal-title":"Nature"},{"key":"38613_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1134\/S000629792103007X","volume":"86","author":"DA Khrabrova","year":"2021","unstructured":"Khrabrova, D. A., Yakubovskaya, M. G. & Gromova, E. S. AML-Associated mutations in DNA methyltransferase DNMT3A. Biochem. (Mosc). 86, 307\u2013318 (2021).","journal-title":"Biochem. (Mosc)"},{"key":"38613_CR12","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41588-022-01179-9","volume":"54","author":"AS Nam","year":"2022","unstructured":"Nam, A. S. et al. Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor States through selective hypomethylation. Nat. Genet. 54, 1514\u20131526 (2022).","journal-title":"Nat. Genet."},{"key":"38613_CR13","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.2147\/CMAR.S201610","volume":"11","author":"W Jing","year":"2019","unstructured":"Jing, W. et al. DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer. Cancer Manag Res. 11, 6379\u20136396 (2019).","journal-title":"Cancer Manag Res."},{"key":"38613_CR14","doi-asserted-by":"publisher","first-page":"216611","DOI":"10.1016\/j.canlet.2024.216611","volume":"586","author":"L Zhu","year":"2024","unstructured":"Zhu, L. et al. Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression. Cancer Lett. 586, 216611 (2024).","journal-title":"Cancer Lett."},{"key":"38613_CR15","doi-asserted-by":"publisher","first-page":"viii36","DOI":"10.1093\/annonc\/mdz385","volume":"30","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly, E. M. & Hechtman, J. F. Tumour response to TRK Inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion. Ann. Oncol. 30, viii36\u2013viii40 (2019).","journal-title":"Ann. Oncol."},{"key":"38613_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","volume":"162","author":"AN Hosein","year":"2022","unstructured":"Hosein, A. N. et al. Loss of Rnf43 accelerates Kras-Mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology 162, 1303\u20131318 (2022). e1318.","journal-title":"Gastroenterology"},{"key":"38613_CR17","doi-asserted-by":"crossref","unstructured":"Huang, G., Cai, X. & Li, D. Significance of targeting DNMT3A mutations in AML, Ann Hematol, (2024).","DOI":"10.1007\/s00277-024-05885-8"},{"key":"38613_CR18","doi-asserted-by":"publisher","first-page":"849376","DOI":"10.3389\/fonc.2022.849376","volume":"12","author":"M Jawad","year":"2022","unstructured":"Jawad, M. et al. DNMT3A R882 mutations confer unique clinicopathologic features in MDS including a high risk of AML transformation. Front. Oncol. 12, 849376 (2022).","journal-title":"Front. Oncol."},{"key":"38613_CR19","doi-asserted-by":"publisher","first-page":"e3519","DOI":"10.1097\/MD.0000000000003519","volume":"95","author":"XQ Yuan","year":"2016","unstructured":"Yuan, X. Q. et al. DNMT3A R882 mutations predict a poor prognosis in AML: A Meta-Analysis from 4474 patients. Med. (Baltim). 95, e3519 (2016).","journal-title":"Med. (Baltim)."},{"key":"38613_CR20","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N Engl. J. Med. 363, 2424\u20132433 (2010).","journal-title":"N Engl. J. Med."},{"key":"38613_CR21","doi-asserted-by":"publisher","first-page":"e26906","DOI":"10.1371\/journal.pone.0026906","volume":"6","author":"J Lin","year":"2011","unstructured":"Lin, J. et al. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One. 6, e26906 (2011).","journal-title":"PLoS One"},{"key":"38613_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell. 25, 442\u2013454 (2014).","journal-title":"Cancer Cell."},{"key":"38613_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood-2014-08-594648","volume":"125","author":"A Mayle","year":"2015","unstructured":"Mayle, A. et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 125, 629\u2013638 (2015).","journal-title":"Blood"},{"key":"38613_CR24","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2013-02-483487","volume":"122","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122, 4086\u20134089 (2013).","journal-title":"Blood"},{"key":"38613_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5045\/br.2020.55.1.17","volume":"55","author":"DJ Park","year":"2020","unstructured":"Park, D. J. et al. Characteristics of DNMT3A mutations in acute myeloid leukemia. Blood Res. 55, 17\u201326 (2020).","journal-title":"Blood Res."},{"key":"38613_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1186\/s12885-021-08915-0","volume":"21","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Dnmt3a is downregulated by Stat5a and mediates G0\/G1 arrest by suppressing the miR-17-5p\/Cdkn1a axis in Jak2(V617F) cells. BMC Cancer. 21, 1213 (2021).","journal-title":"BMC Cancer"},{"key":"38613_CR27","doi-asserted-by":"publisher","first-page":"eabl5220","DOI":"10.1126\/sciadv.abl5220","volume":"8","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity. Sci. Adv. 8, eabl5220 (2022).","journal-title":"Sci. Adv."},{"key":"38613_CR28","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1158\/0008-5472.CAN-18-3275","volume":"79","author":"R Lu","year":"2019","unstructured":"Lu, R. et al. A model system for studying the DNMT3A hotspot mutation (DNMT3A(R882)) demonstrates a causal relationship between its Dominant-Negative effect and leukemogenesis. Cancer Res. 79, 3583\u20133594 (2019).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38613-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:36:24Z","timestamp":1772098584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38613-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38613"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38613-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Jining No. 1 People\u2019s Hospital. The research protocols were conformed to the tenets of the Declaration of Helsinki. Informed consents were taken from patients for publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7659"}}